20th Feb 2008 11:14
GlaxoSmithKline PLC20 February 2008 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons The Administrators of the GlaxoSmithKline Performance Share Plan notified theCompany and the under-mentioned persons on 19 February 2008 of an increase intheir notional interests in Ordinary shares at a price of £11.04 per share andOrdinary Share ADRs at a price of $43.66 per ADR following the notionalre-investment of the dividend to which shareholders entered on the register ofmembers at the close of business on 15 February 2008 are entitled to receive. Ordinary shares ADRsDr J-P Garnier* 10,082.53Mr A P Witty* 3,688.75Mr R M Bondy 3,569.48Mr J M Clarke 2,760.79Mr M Dunoyer 1,344.35Mr E J Gray 547.01Mr J S Heslop* 3,354.38Mr D Learmouth 491.97Dr M Slaoui* 599.07 1,019.65Dr R G Greig 1,148.27Mr W C Louv 532.06Mr D J Phelan 1,768.34Dr D Pulman 1,148.27Mr D M Stout 4,212.02Mr C Viehbacher* 1,827.45 * denotes the individual is an Executive Director Dr Slaoui's connected person, who is also an employee of the Company, alsoreceived 52.17 Ordinary shares and 23.20 ADRs following the notionalreinvestment of the aforementioned dividend. The notional dividends accrued will be paid out in proportion to the percentageof participants' Performance Share Plan holdings that vest following the end ofthe relevant three year measurement period. This notification relates to transactions notified in accordance with Disclosureand Transparency Rule 3.1.4R(1)(a). S M BicknellCompany Secretary 20 February 2008 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline